New and Emerging Treatments for Patients with Lymphatic Disease
Please join us for the Morris and Carolyn Barkon Lectureship in Gynecological Oncology Survivorship featuring Stanley G. Rockson, MD, Director, Center for Lymphatic and Venous Disorders, Stanford University School of Medicine.
Lymphatic disorders often have profound functional and psychological implications for patients and their families. Caring for patients with edema is a complex task requiring input from many specialists. Dr. Rockson will address new and emerging lymphatic disorders.
It will include an interactive question and answer session. This lectureship is made possible by the generosity of Dr. Beverly Barkon and Dr. Frank Lieberman.
This presentation is designed for physicians, nursing and any health care professional interested in learning more on lymphatic disease.
Participation in this program will enable the participant to recognize the risks of lymphedema in cancer treatment and to recognize the clinical presentation of these patients. Risk reduction and management strategies will be covered.
4:00 p.m. New and Emerging Treatments in Patients with Lymphatic Disease - Stanley G. Rockson, MD
5:00 p.m. Adjournment
Presenter: Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Professor of Cardiovascular Medicine
Stanford University School of Medicine
Moderator: Colleen Straub
Director of Development
Magee-Womens Research Institute & Foundation
Course Director: Linda Ankrom, MSN
Director of Operations
Women’s Cancer Center
UPMC Magee-Womens Hospital
Course Director: Frank Lieberman, MD
Department of Neurology
UPMC Hillman Cancer Center
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Stanley Rockson – receives grant/research support from Fibralign, Inc. and is a consultant/stockholder for Koya, Inc.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation and Designation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance